Tage Honore

Insider Reports History

Entity
Individual
Location
C/O Vanda Pharmaceuticals Inc., 2200 Pennsylvania Avenue, Suite 300 E, Washington, DC
Signature
/s/ Tage Honore
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tage Honore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. Director Common Stock 64.2K $269K $4.18 May 17, 2024 Direct
Vanda Pharmaceuticals Inc. Director Stock Option (right to buy) 37.6K May 17, 2024 Direct

Insider Reports Filed by Tage Honore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VNDA Vanda Pharmaceuticals Inc. May 17, 2024 2 $0 4 May 21, 2024 Director
VNDA Vanda Pharmaceuticals Inc. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
VNDA Vanda Pharmaceuticals Inc. Mar 15, 2023 2 $0 4 Mar 17, 2023 Director
VNDA Vanda Pharmaceuticals Inc. Mar 15, 2023 0 $0 3 Mar 17, 2023 Director